Sucostrin

NDA 8847, held by Apothecon. Succinylcholine Chloride.

As of Nov 14, 2026, NDA 8847 (Sucostrin), held by Apothecon, was first approved by FDA on Apr 24, 1953, with 8 approved supplements and 0 published complete response letters.

First approved: Apr 24, 1953
Review: Standard
Supplements approved: 8
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 9 submissions below

Date	Submission	Status	Documents
Apr 24, 1953	Original applicationNew formulation or manufacturer · Standard review	Approved	None posted

Products

2 strengths and forms


Sucostrin20MG/ML · injectable;injection	Succinylcholine Chloride	DiscontinuedReference drug
Sucostrin100MG/ML · injectable;injection	Succinylcholine Chloride	DiscontinuedReference drug

All 9 submissions, including labeling and manufacturing supplements


Mar 28, 1997	Supplement 11Labeling · Standard review	Approved	None posted
Nov 28, 1994	Supplement 10Labeling · Standard review	Approved	None posted
Nov 19, 1984	Supplement 6Labeling	Approved	None posted
Dec 14, 1982	Supplement 7Labeling	Approved	None posted
May 15, 1978	Supplement 5Labeling	Approved	None posted
Oct 21, 1977	Supplement 2Labeling	Approved	None posted
Feb 24, 1977	Supplement 4Labeling	Approved	None posted
Apr 4, 1973	Supplement 1Labeling	Approved	None posted
Apr 24, 1953	Original applicationNew formulation or manufacturer · Standard review	Approved	None posted

Identifiers

Application: NDA 8847
Drugs@FDA: Overview at FDA
Company: Apothecon

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters